ELPEN Pharmaceutical Co. Inc.

Address: ELPEN Pharmaceutical, 95 Marathonos Av.
190 09 Pikermi Greece
Phone: +30210603 93 26
Fax: +30210 603 93 00
Web: http://www.elpen.gr

Contact person: Mrs. Elina Mertzanou
Correspondence: English
Foundation: 1965
Operation Level: International

ELPEN Pharmaceutical
ELPEN
Pharmaceutical

...  Video



...  Exhibitions

CPHI CHINA incorporating ICSE CHINA in conjunction with P-MEC
International pharmaceutical industry trade fair
21/06/2016 - 23/06/2016
Location SNIEC - Shanghai New International Expo Center
Shanghai
China, P.R.

CPHI WORLDWIDE
International exhibition on pharmaceutical ingredients and intermediates
09/10/2018 - 11/10/2018
Location IFEMA Feria de Madrid
Madrid (changing)
Spain

CPHI WORLDWIDE: FDF
International trade fair on finished dosage formulation
09/10/2018 - 11/10/2018
Location IFEMA Feria de Madrid
Madrid (changing)
Spain

ERS CONGRESS
International congress of respiratory science and medicine
28/09/2019 - 02/10/2019
Location Paris expo Porte de Versailles
Paris (changing)
France

ARAB HEALTH
International hospital, medical equipment and services exhibition and conference
29/01/2018 - 01/02/2018
Location DWTC Dubai World Trade Center
Dubai
United Arab Emirates


... Business Description

ELPEN is a privately owned, Greek pharmaceutical company with more than 780 employees and operations worldwide.

Established in 1965, the group currently ranks as 1st among Greek companies and 6th overall among 400 companies operating in Greece.

All products are manufactured and developed under strict EU guidelines on ELPEN’s production facility of 10.000m2 located in Pikermi, Greece.

Examples of ELPEN’s R&D activities include the Elpenhaler® DPI products already marketed worldwide.

For more information please visit us at www.elpen.gr


... Company Profile

ELPEN is a leading Greek private Pharmaceutical industry with more than 780 employees and annual turnover of € 155M. With state of the art production and research facilities, ELPEN specializes in the development, production and commercialization of generic products and value added medicines across five continents.